Original news and analysis on international IP policy
The first meeting of the World Health Organization mechanism intended to promote the prevention and control of “substandard/spurious/falsely-labelled/falsified/counterfeit” (SSFFC) medical products is being called a success. Member states agreed on a work plan that focuses on strengthening regulatory capacities and decided to form a steering committee to monitor country compliance to the plan.
The World Trade Organization Dispute Settlement Body yesterday heard arguments by parties in a dispute about Australia's new public health law requiring tobacco imports to be in plain packaging as a way to discourage tobacco use. Honduras presented a challenge to the Australian law, saying it is not in line with WTO rules on intellectual property rights, while Australia said it is a "sound, well-considered" action in the name of public health.
World Health Organization Director General Margaret Chan today issued a statement attempting to clarify the UN agency's relationship with the industries - like producers of junk food and soda - in line to be regulated as the UN moves to battle globally rising noncommunicable diseases (NCDs) like diabetes, heart disease and cancer.
The Board of the Global Fund to Fight AIDS, Tuberculosis and Malaria appointed Ambassador Mark Dybul, a former US Global AIDS Coordinator, as the new head of the organisation. Additionally, the Board decided to move forward on implementing a new funding model, replacing the rounds-based system.
The Drugs for Neglected Diseases initiative (DNDi) and Medicines for Malaria Venture (MMV) announced the identification of three potential drug classes for the treatment of neglected tropical diseases through the availability of hundreds of compounds in the public domain.
Greg Perry, a longtime leader in the European generics industry, has been named the new executive director of the Medicines Patent Pool, a cutting-edge Geneva-based group working to increase access to affordable, high-quality medicines for HIV/AIDS patients in low and middle income countries.
The industry practice of extending patent protection on pharmaceuticals by obtaining additional patents on other features of the drug ingredients can lead to decades of delay in generic competition, a new study argues.
World Health Organization members this week achieved consensus on a set of voluntary targets and indicators for the prevention and control of the world’s biggest killers including cancer, diabetes, cardiovascular and chronic respiratory diseases. Two targets and several indicators relate to national health systems response.
An outside meeting of experts has prepared a report ahead of this month’s gathering of World Health Organization members hoping to agree on new models for financing research and development for diseases lacking adequate market mechanisms and public policies. These include neglected diseases that predominantly affect poor populations unable to pay high prices needed to defray R&D costs under the existing commercial model.
The International Federation of Pharmaceutical Manufacturers and Associations (IFPMA) held its 26th assembly this week and elected its new president. He presented the future orientation of the industry group, saying will work on trust-building and needs predictability in the regulatory process, policies that sustain and encourage innovation, and a strong intellectual property system, he said.